Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 79

1.

Amyloid cardiomyopathy as initial presentation of multiple myeloma: devil is in the details.

Pawar A, Sabnis G, Kerkar P.

Eur Heart J. 2019 Sep 23. pii: ehz668. doi: 10.1093/eurheartj/ehz668. [Epub ahead of print] No abstract available.

PMID:
31557283
2.

A case report: metastatic complete heart block.

Kumar D, Mankame P, Sabnis G, Nabar A.

Eur Heart J Case Rep. 2018 Nov 29;2(4):yty131. doi: 10.1093/ehjcr/yty131. eCollection 2018 Dec.

3.

Validation of "left ventricular early inflow-outflow index": A novel echocardiographic method for quantification of mitral regurgitation in an Indian population with special focus on rheumatic etiology.

Lanjewar C, Pawar A, Patil D, Dhavalagimath M, Sabnis G, Shah H, Kerkar P.

Indian Heart J. 2018 Dec;70 Suppl 3:S235-S240. doi: 10.1016/j.ihj.2018.08.007. Epub 2018 Aug 29.

4.

A critical analysis of the COMPASS trial with respect to benefit-risk assessment using the numbers needed to treat: Applicability and relevance in Indian patients with stable cardiovascular disease.

Kerkar P, Bose D, Nishandar T, Sabnis G, Kumar D, Thatte UM, Gogtay NJ.

Indian Heart J. 2018 Nov - Dec;70(6):911-914. doi: 10.1016/j.ihj.2018.06.006. Epub 2018 Aug 22. Review.

5.

Transcatheter closure of large aortopulmonary window in a neonate.

Sabnis GR, Shah HC, Lanjewar CP, Malik S, Kerkar PG.

Ann Pediatr Cardiol. 2018 May-Aug;11(2):228-230. doi: 10.4103/apc.APC_158_17. No abstract available.

6.

A rare endocrine cause of electrical storm - a case report.

Shinde SD, Sabnis GR, Lanjewar CP, Kerkar PG.

Eur Heart J Case Rep. 2017 Nov 7;1(2):ytx008. doi: 10.1093/ehjcr/ytx008. eCollection 2017 Dec.

7.

Appropriateness of elective percutaneous coronary intervention and impact of government health insurance scheme - A tertiary centre experience from Western India.

Patil D, Lanjewar C, Vaggar G, Bhargava J, Sabnis G, Pahwa J, Phatarpekar A, Shah H, Kerkar P.

Indian Heart J. 2017 Sep - Oct;69(5):600-606. doi: 10.1016/j.ihj.2016.12.018. Epub 2017 Jan 13.

8.

The trilayer approach of teaching physiology, pathophysiology, and pharmacology concepts in a first-year pharmacy course: the TLAT model.

Islam MA, Sabnis G, Farris F.

Adv Physiol Educ. 2017 Sep 1;41(3):395-404. doi: 10.1152/advan.00047.2017.

9.

A rare and treatable cause of hypertension in pregnancy.

Bhargava RA, Sabnis GR, Phatarpekar A, Lanjewar CP, Shah HC, Kerkar PG.

J Clin Hypertens (Greenwich). 2017 Aug;19(8):801-802. doi: 10.1111/jch.13029. Epub 2017 May 26. No abstract available.

10.

Percutaneous balloon valvuloplasty with Inoue balloon catheter technique for pulmonary valve stenosis in adolescents and adults.

Lanjewar C, Phadke M, Singh A, Sabnis G, Jare M, Kerkar P.

Indian Heart J. 2017 Mar - Apr;69(2):176-181. doi: 10.1016/j.ihj.2016.11.316. Epub 2017 Mar 1.

11.

Treatment with an orally bioavailable prodrug of 17β-estradiol alleviates hot flushes without hormonal effects in the periphery.

Merchenthaler I, Lane M, Sabnis G, Brodie A, Nguyen V, Prokai L, Prokai-Tatrai K.

Sci Rep. 2016 Aug 1;6:30721. doi: 10.1038/srep30721.

12.

Echocardiographic parameters in clinical responders to surgical pericardiectomy - A single center experience with chronic constrictive pericarditis.

Patil DV, Sabnis GR, Phadke MS, Lanjewar CP, Mishra P, Kulkarni DV, Agrawal NB, Kerkar PG.

Indian Heart J. 2016 May-Jun;68(3):316-24. doi: 10.1016/j.ihj.2015.09.027. Epub 2016 Jan 11.

13.

Percutaneous tricuspid valvotomy for pacemaker lead-induced tricuspid stenosis.

Patil DV, Nabar AA, Sabnis GR, Phadke MS, Lanjewar CP, Kerkar PG.

Indian Heart J. 2015 Dec;67 Suppl 3:S115-6. doi: 10.1016/j.ihj.2015.06.033. Epub 2016 Jan 14.

14.

Classical Cardiovascular Manifestations of Marfan Syndrome.

Sabnis GR, Patil DV, Phadke MS, Lanjewar CP, Nabar AA, Kerkar PG.

J Assoc Physicians India. 2015 Jul;63(7):65-7.

PMID:
26731833
15.

Complete Heart Block due to Aortic Root Abscesses.

Sabnis GR, Patil DV, Sharma R, Phadke MS, Lanjewar CP, Nabar AA, Kerkar PG.

J Assoc Physicians India. 2015 Jun;63(6):61-2. No abstract available.

PMID:
26710402
16.

A classical case of the Gasul phenomenon.

Sabnis GR, Phadke MS, Kerkar PG.

Cardiol Young. 2016 Feb;26(2):363-4. doi: 10.1017/S1047951115002401. Epub 2015 Oct 28.

PMID:
26506861
17.

Seribantumab, an Anti-ERBB3 Antibody, Delays the Onset of Resistance and Restores Sensitivity to Letrozole in an Estrogen Receptor-Positive Breast Cancer Model.

Curley MD, Sabnis GJ, Wille L, Adiwijaya BS, Garcia G, Moyo V, Kazi AA, Brodie A, MacBeath G.

Mol Cancer Ther. 2015 Nov;14(11):2642-52. doi: 10.1158/1535-7163.MCT-15-0169. Epub 2015 Aug 26.

18.

The prodrug DHED selectively delivers 17β-estradiol to the brain for treating estrogen-responsive disorders.

Prokai L, Nguyen V, Szarka S, Garg P, Sabnis G, Bimonte-Nelson HA, McLaughlin KJ, Talboom JS, Conrad CD, Shughrue PJ, Gould TD, Brodie A, Merchenthaler I, Koulen P, Prokai-Tatrai K.

Sci Transl Med. 2015 Jul 22;7(297):297ra113. doi: 10.1126/scitranslmed.aab1290.

19.

Histone deacetylase inhibitor entinostat in combination with a retinoid downregulates HER2 and reduces the tumor initiating cell population in aromatase inhibitor-resistant breast cancer.

Schech AJ, Shah P, Yu S, Sabnis GJ, Goloubeva O, Rosenblatt P, Kazi A, Chumsri S, Brodie A.

Breast Cancer Res Treat. 2015 Aug;152(3):499-508. doi: 10.1007/s10549-015-3442-z. Epub 2015 Jul 2.

PMID:
26133921
20.

A nude mouse model of obesity to study the mechanisms of resistance to aromatase inhibitors.

Schech A, Yu S, Goloubeva O, McLenithan J, Sabnis G.

Endocr Relat Cancer. 2015 Aug;22(4):645-56. doi: 10.1530/ERC-15-0168. Epub 2015 Jun 25.

PMID:
26113604
21.

Histone Deacetylase Inhibitor Entinostat Inhibits Tumor-Initiating Cells in Triple-Negative Breast Cancer Cells.

Schech A, Kazi A, Yu S, Shah P, Sabnis G.

Mol Cancer Ther. 2015 Aug;14(8):1848-57. doi: 10.1158/1535-7163.MCT-14-0778. Epub 2015 Jun 2.

22.

Classic cor triatriatum with opposing shunts at the atrial level: a rare association.

Sabnis GR, Udare AS, Phadke MS, Kerkar PG.

Eur Heart J. 2015 Oct 7;36(38):2594. doi: 10.1093/eurheartj/ehv099. Epub 2015 Apr 16. No abstract available.

PMID:
25883175
23.

An extremely rare cause of Eisenmenger syndrome.

Phadke MS, Sabnis GR, Patil DV, Lanjewar CP, Kerkar PG.

Indian Heart J. 2014 Nov-Dec;66(6):737-9. doi: 10.1016/j.ihj.2014.10.397. Epub 2014 Nov 5.

24.

Idiopathic pseudoaneurysm of mitral-aortic intervalvular fibrosa with rupture into the left atrium.

Sabnis GR, Phadke MS, Patil DV, Lanjewar CP, Kerkar PG.

Eur Heart J Cardiovasc Imaging. 2015 Apr;16(4):456. doi: 10.1093/ehjci/jeu278. Epub 2014 Dec 2. No abstract available.

PMID:
25468959
25.

Combined cancer therapy: strategies to overcome acquired aromatase inhibitor resistance.

Kesmodel SB, Sabnis GJ, Chumsri S, Brodie AM.

Curr Pharm Des. 2014;20(42):6575-83. Review.

PMID:
25341934
26.

Differential cyanosis and clubbing sparing a single limb.

Sabnis GR, Phadke MS, Lanjewar CP, Kerkar PG, Nabar AA.

J Am Coll Cardiol. 2014 Apr 15;63(14):e33. doi: 10.1016/j.jacc.2013.11.058. Epub 2014 Feb 19. No abstract available.

27.

mTOR inhibitors: changing landscape of endocrine-resistant breast cancer.

Chumsri S, Sabnis G, Tkaczuk K, Brodie A.

Future Oncol. 2014 Feb;10(3):443-56. doi: 10.2217/fon.13.178. Review.

PMID:
24559450
28.

Advances in mechanisms of resistance to aromatase inhibitors.

Chumsri S, Schech A, Chakkabat C, Sabnis G, Brodie A.

Expert Rev Anticancer Ther. 2014 Apr;14(4):381-93. doi: 10.1586/14737140.2014.882233. Epub 2014 Feb 22. Review.

PMID:
24559291
29.

Nonhypoxic regulation and role of hypoxia-inducible factor 1 in aromatase inhibitor resistant breast cancer.

Kazi AA, Gilani RA, Schech AJ, Chumsri S, Sabnis G, Shah P, Goloubeva O, Kronsberg S, Brodie AH.

Breast Cancer Res. 2014 Jan 29;16(1):R15. doi: 10.1186/bcr3609.

30.

Histone deacetylase inhibitor entinostat reverses epithelial to mesenchymal transition of breast cancer cells by reversing the repression of E-cadherin.

Shah P, Gau Y, Sabnis G.

Breast Cancer Res Treat. 2014 Jan;143(1):99-111. doi: 10.1007/s10549-013-2784-7. Epub 2013 Dec 5.

PMID:
24305977
31.

HDAC inhibitor entinostat restores responsiveness of letrozole-resistant MCF-7Ca xenografts to aromatase inhibitors through modulation of Her-2.

Sabnis GJ, Goloubeva OG, Kazi AA, Shah P, Brodie AH.

Mol Cancer Ther. 2013 Dec;12(12):2804-16. doi: 10.1158/1535-7163.MCT-13-0345. Epub 2013 Oct 3.

32.

Effect of selumetinib on the growth of anastrozole-resistant tumors.

Sabnis GJ, Kazi A, Golubeva O, Shah P, Brodie A.

Breast Cancer Res Treat. 2013 Apr;138(3):699-708. doi: 10.1007/s10549-013-2474-5. Epub 2013 Mar 19.

PMID:
23508762
33.

The importance of HER2 signaling in the tumor-initiating cell population in aromatase inhibitor-resistant breast cancer.

Gilani RA, Kazi AA, Shah P, Schech AJ, Chumsri S, Sabnis G, Jaiswal AK, Brodie AH.

Breast Cancer Res Treat. 2012 Oct;135(3):681-92. doi: 10.1007/s10549-012-2148-8. Epub 2012 Aug 10.

PMID:
22878889
34.

Dapsone-induced neutropenia with invasive pulmonary aspergillosis.

Sabnis GR, Kulkarni UP, Gokhale YA.

Lung India. 2012 Apr;29(2):185-6. doi: 10.4103/0970-2113.95340. No abstract available.

35.

Synthesis and in vitro characterization of semitelechelic poly[N-(2-hydroxypropyl)methacrylamide]-trastuzumab conjugates targeted to breast cancer.

Lee JH, Sabnis G, Nan A.

Macromol Biosci. 2012 Jan;12(1):55-60. doi: 10.1002/mabi.201100152. Epub 2011 Aug 25.

PMID:
22052593
36.

Gingival enlargement due to Cyclosporine A therapy in aplastic anaemia.

Sabnis GR, Karnik ND, Sundar U, Adwani S.

Indian J Pharmacol. 2011 Sep;43(5):613-4. doi: 10.4103/0253-7613.84988. No abstract available.

37.

Acute aortic syndrome--penetrating atherosclerotic ulcer with contained rupture managed by endovascular stent-grafting.

Sabnis GR, Trivedi TH, Kamath SA, Moulick ND, Deshmukh H, Rathod K.

J Assoc Physicians India. 2011 Jan;59:59-61.

PMID:
21751671
38.

Trauma precipitating thyroid storm.

Sabnis GR, Karnik ND, Chavan SA, Korivi DS, Pati MV.

J Assoc Physicians India. 2011 Feb;59:117-9.

PMID:
21751651
39.

Extranodal NK/T cell lymphoma presenting as palatal perforation with oronasal fistula.

Chaudhary SV, Karnik ND, Sabnis GR, Patil MV, Bradoo RA.

J Assoc Physicians India. 2011 Feb;59:112-4.

PMID:
21751648
40.

Young male with syncope, absent lower limb pulses, hypertension and systolic murmur.

Sabnis GR, Gokhale YA, Kulkarni UP, Joshi AR.

J Assoc Physicians India. 2011 Jun;59:374. No abstract available.

PMID:
21751592
41.

Recurrent pyogenic meningitis in a 17-year-old: a delayed presentation of X-linked agammaglobulinemia with growth hormone deficiency.

Sabnis GR, Karnik ND, Chavan SA, Korivi DS.

Neurol India. 2011 May-Jun;59(3):435-7. doi: 10.4103/0028-3886.82768.

42.

GP88 (PC-Cell Derived Growth Factor, progranulin) stimulates proliferation and confers letrozole resistance to aromatase overexpressing breast cancer cells.

Abrhale T, Brodie A, Sabnis G, Macedo L, Tian C, Yue B, Serrero G.

BMC Cancer. 2011 Jun 9;11:231. doi: 10.1186/1471-2407-11-231.

43.

Aromatase inhibitors and xenograft studies.

Chumsri S, Sabnis GJ, Howes T, Brodie AM.

Steroids. 2011 Jul;76(8):730-5. doi: 10.1016/j.steroids.2011.02.033. Epub 2011 Mar 21.

44.

Adaptive changes result in activation of alternate signaling pathways and acquisition of resistance to aromatase inhibitors.

Brodie A, Sabnis G.

Clin Cancer Res. 2011 Jul 1;17(13):4208-13. doi: 10.1158/1078-0432.CCR-10-2920. Epub 2011 Mar 17.

45.

Extending aromatase inhibitor sensitivity in hormone resistant breast cancer.

Brodie AM, Chumsri S, Sukumar S, Sabnis GJ.

Horm Mol Biol Clin Investig. 2011 Mar 1;5(2):97-103. doi: 10.1515/HMBCI.2011.010.

PMID:
25961245
46.

Aromatase, aromatase inhibitors, and breast cancer.

Chumsri S, Howes T, Bao T, Sabnis G, Brodie A.

J Steroid Biochem Mol Biol. 2011 May;125(1-2):13-22. doi: 10.1016/j.jsbmb.2011.02.001. Epub 2011 Feb 16. Review.

47.

Functional activation of the estrogen receptor-α and aromatase by the HDAC inhibitor entinostat sensitizes ER-negative tumors to letrozole.

Sabnis GJ, Goloubeva O, Chumsri S, Nguyen N, Sukumar S, Brodie AM.

Cancer Res. 2011 Mar 1;71(5):1893-903. doi: 10.1158/0008-5472.CAN-10-2458. Epub 2011 Jan 18.

48.
49.

Upregulation of AIB1, aromatase and ERα provides long-term estrogen-deprived human breast cancer cells with a mechanistic growth advantage for survival.

Tilghman SL, Sabnis G, Brodie AM.

Horm Mol Biol Clin Investig. 2010 Dec 1;3(1):357-66. doi: 10.1515/HMBCI.2010.042.

PMID:
25961207
50.

Pancoast tumour presenting as paraplegia with Horner's syndrome.

Karnik ND, Sabnis GR, Chavan SA.

J Assoc Physicians India. 2010 Apr;58:232. No abstract available.

PMID:
21046878

Supplemental Content

Loading ...
Support Center